RIYADH, Saudi Arabia & TOKYO--(BUSINESS WIRE)--Recursive Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Tiago Ramalho; hereinafter referred to as "Recursive"), a developer of AI solutions that facilitate ...

Advances in AI are enabling systems to contribute to the design, coding, and optimization of future AI models, edging closer to the long-debated concept of recursive self-improvement (RSI). While ...

As it continues to branch out from the silicon world into the living one, the artificial intelligence-powered drug discovery company Recursion Pharmaceuticals has moved to acquire Vium, developer of ...

Nvidia’s forthright ambitions to expand its drug development footprint are coming into focus, with the global computing powerhouse announcing a trio of new initiatives including a new collaboration ...

Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients Drug discovery research collaboration may initiate up to seven oncology ...